Andrew Ambrosy to Retrospective Studies
This is a "connection" page, showing publications Andrew Ambrosy has written about Retrospective Studies.
Connection Strength
0.647
-
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
Score: 0.117
-
Hyperglycemia and outcomes in acute heart failure - A bittersweet relationship. Int J Cardiol. 2020 02 01; 300:196-197.
Score: 0.103
-
Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Am Heart J. 2018 05; 199:97-104.
Score: 0.091
-
Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure. Am J Cardiol. 2015 Apr 01; 115(7):938-41.
Score: 0.074
-
The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175.
Score: 0.043
-
Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755.
Score: 0.030
-
Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022 04; 9(2):947-952.
Score: 0.030
-
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. JAMA Cardiol. 2020 06 01; 5(6):643-651.
Score: 0.027
-
Spontaneous Coronary Artery Dissection and Incident Ventricular Arrhythmias: Frequency, Clinical Characteristics, and Outcomes. JACC Cardiovasc Interv. 2020 02 24; 13(4):539-541.
Score: 0.026
-
Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials. Curr Heart Fail Rep. 2017 02; 14(1):30-39.
Score: 0.021
-
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Circ Heart Fail. 2016 09; 9(9).
Score: 0.021
-
Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014 May; 7(3):401-8.
Score: 0.017
-
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). Am J Cardiol. 2013 Dec 01; 112(11):1763-9.
Score: 0.017
-
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J. 2012 Dec; 164(6):884-92.e2.
Score: 0.016
-
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012 May; 17(3):485-509.
Score: 0.015